Investors

Insider Transactions

Date Sorted Ascending Name Title Type Shares Traded Price Range
Dec 20, 2007 sanofi Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Dec 20, 2007 schleifer leonard s Officer Option Execute 37,370 8.63
Dec 20, 2007 schleifer leonard s Officer Automatic Sell 22,207 22.28
Dec 24, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Jan 3, 2008 vagelos p roy Director Automatic Sell 8,658 n/a
Jan 17, 2008 brown michael s Director Automatic Sell 200 25.00
Jan 22, 2008 brown michael s Director Automatic Sell 9,800 25.00
Jan 22, 2008 goldstein joseph l Director Option Execute 5,000 7.66
Jan 22, 2008 goldstein joseph l Director Automatic Sell 5,000 25.00
Feb 15, 2008 baker charles a Director Option Execute 10,000 7.91
Feb 15, 2008 baker charles a Director Automatic Sell 10,000 18.67 - 19.06
Feb 20, 2008 gilman alfred g Director Option Execute 10,000 7.91
Feb 27, 2008 vagelos p roy Director Option Execute 6,666 7.91
Mar 29, 2008 vagelos p roy Director Disposition (Non Open Market) 10,669 n/a
May 30, 2008 shooter eric m Director Option Execute 15,000 9.17
May 30, 2008 shooter eric m Director Sell 15,000 19.80 - 19.88
Jun 13, 2008 vagelos p roy Director Disposition (Non Open Market) 115,082 n/a
Jun 13, 2008 vagelos p roy Director Acquisition (Non Open Market) 115,082 n/a
Jul 9, 2008 vagelos p roy Director Disposition (Non Open Market) 8,105 n/a
Jul 10, 2008 vagelos p roy Director Disposition (Non Open Market) 30,705 n/a
Showing 21-40 of 840 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)